These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Phenylphthalimides with tumor necrosis factor alpha production-enhancing activity.
    Author: Shibata Y, Sasaki K, Hashimoto Y, Iwasaki S.
    Journal: Chem Pharm Bull (Tokyo); 1996 Jan; 44(1):156-62. PubMed ID: 8582037.
    Abstract:
    Phenylphthalimides (2-phenyl-1H-isoindole-1,3-diones) were prepared and their effects on tumor necrosis factor alpha (TNF-alpha) production by human leukemia cell line HL-60 stimulated with 12-O-tetradecanoylphorbol-13-acetate (TPA) were examined. An analysis of the structure-activity relationships of the phenylphthalimides indicated that potent enhancing activity on TPA-induced TNF-alpha production by HL-60 cells requires medium-sized substituent(s) at the ortho position(s) of the phenyl group; 2-(2,6-diisopropylphenyl)-1H-isoindole-1,3-dione (PP-33) increased the TNF-alpha production to more than 600% at the concentration of 1 x 10(-5) M. Introduction of a nitro group at the phthalimide moiety of PP-33 enhanced the activity; 2-(2,6-diisopropylphenyl)-4-nitro-1H-isoindole-1,3-dione (4NPP-33) and its 5-nitro isomer (5NPP-33) enhanced the TNF-alpha production to more than 800% and 700%, respectively, at the concentration of 1 x 10(-5) M. Introduction of fluorines into the phthalimide moiety of PP-33 greatly lowered the concentration of the compound necessary to elicit the TNF-alpha production-enhancing activity; 2-(2,6-diisopropylphenyl)-4,5,6,7-tetrafluoro-1H-isoindole-1,3-dio ne (FPP-33) showed the activity at nanomolar concentration, with the optimum concentration of 1 x 10(-7) M.
    [Abstract] [Full Text] [Related] [New Search]